The global Motion Sickness Pills market was valued at US$ 878.7 million in 2022 and is projected to reach US$ 1078.3 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The motion sickness pills market is driven by several factors. One of the primary drivers is the increasing prevalence of motion sickness among individuals traveling by various modes of transportation, such as cars, planes, trains, and boats. Motion sickness, characterized by symptoms like nausea, dizziness, and vomiting, affects a significant portion of the population, leading to a rising demand for effective treatment options. Additionally, the growing tourism and travel industry, coupled with the increasing popularity of adventure and recreational activities, have expanded the potential consumer base for motion sickness pills. The convenience and ease of use offered by these pills, providing quick relief from symptoms, further contribute to their market growth. Moreover, advancements in drug formulations, such as non-drowsy and long-lasting options, have improved patient compliance and satisfaction. Additionally, the availability of over-the-counter options and increased accessibility of these medications in pharmacies and online platforms have further fueled the demand for motion sickness pills. Overall, the motion sickness pills market is driven by the increasing prevalence of motion sickness, expanding travel industry, advancements in drug formulations, and improved accessibility to these medications.
Motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
This report aims to provide a comprehensive presentation of the global market for Motion Sickness Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Motion Sickness Pills. This report contains market size and forecasts of Motion Sickness Pills in global, including the following market information:
Global Motion Sickness Pills Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Motion Sickness Pills companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Motion Sickness Pills Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Motion Sickness Pills Market Segment Percentages, by Type, 2022 (%)
Anticholinergic
Antihistamines
Others
Global Motion Sickness Pills Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Motion Sickness Pills Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Motion Sickness Pills Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Motion Sickness Pills Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Motion Sickness Pills revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Motion Sickness Pills revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Vartaris
Novartis
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Motion Sickness Pills, market overview.
Chapter 2: Global Motion Sickness Pills market size in revenue.
Chapter 3: Detailed analysis of Motion Sickness Pills company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Motion Sickness Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Motion Sickness Pills Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Motion Sickness Pills Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Motion Sickness Pills Overall Market Size
2.1 Global Motion Sickness Pills Market Size: 2022 VS 2029
2.2 Global Motion Sickness Pills Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Motion Sickness Pills Players in Global Market
3.2 Top Global Motion Sickness Pills Companies Ranked by Revenue
3.3 Global Motion Sickness Pills Revenue by Companies
3.4 Top 3 and Top 5 Motion Sickness Pills Companies in Global Market, by Revenue in 2022
3.5 Global Companies Motion Sickness Pills Product Type
3.6 Tier 1, Tier 2 and Tier 3 Motion Sickness Pills Players in Global Market
3.6.1 List of Global Tier 1 Motion Sickness Pills Companies
3.6.2 List of Global Tier 2 and Tier 3 Motion Sickness Pills Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Motion Sickness Pills Market Size Markets, 2022 & 2029
4.1.2 Anticholinergic
4.1.3 Antihistamines
4.1.4 Others
4.2 By Type - Global Motion Sickness Pills Revenue & Forecasts
4.2.1 By Type - Global Motion Sickness Pills Revenue, 2018-2023
4.2.2 By Type - Global Motion Sickness Pills Revenue, 2024-2029
4.2.3 By Type - Global Motion Sickness Pills Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Motion Sickness Pills Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Motion Sickness Pills Revenue & Forecasts
5.2.1 By Application - Global Motion Sickness Pills Revenue, 2018-2023
5.2.2 By Application - Global Motion Sickness Pills Revenue, 2024-2029
5.2.3 By Application - Global Motion Sickness Pills Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Motion Sickness Pills Market Size, 2022 & 2029
6.2 By Region - Global Motion Sickness Pills Revenue & Forecasts
6.2.1 By Region - Global Motion Sickness Pills Revenue, 2018-2023
6.2.2 By Region - Global Motion Sickness Pills Revenue, 2024-2029
6.2.3 By Region - Global Motion Sickness Pills Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Motion Sickness Pills Revenue, 2018-2029
6.3.2 US Motion Sickness Pills Market Size, 2018-2029
6.3.3 Canada Motion Sickness Pills Market Size, 2018-2029
6.3.4 Mexico Motion Sickness Pills Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Motion Sickness Pills Revenue, 2018-2029
6.4.2 Germany Motion Sickness Pills Market Size, 2018-2029
6.4.3 France Motion Sickness Pills Market Size, 2018-2029
6.4.4 U.K. Motion Sickness Pills Market Size, 2018-2029
6.4.5 Italy Motion Sickness Pills Market Size, 2018-2029
6.4.6 Russia Motion Sickness Pills Market Size, 2018-2029
6.4.7 Nordic Countries Motion Sickness Pills Market Size, 2018-2029
6.4.8 Benelux Motion Sickness Pills Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Motion Sickness Pills Revenue, 2018-2029
6.5.2 China Motion Sickness Pills Market Size, 2018-2029
6.5.3 Japan Motion Sickness Pills Market Size, 2018-2029
6.5.4 South Korea Motion Sickness Pills Market Size, 2018-2029
6.5.5 Southeast Asia Motion Sickness Pills Market Size, 2018-2029
6.5.6 India Motion Sickness Pills Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Motion Sickness Pills Revenue, 2018-2029
6.6.2 Brazil Motion Sickness Pills Market Size, 2018-2029
6.6.3 Argentina Motion Sickness Pills Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Motion Sickness Pills Revenue, 2018-2029
6.7.2 Turkey Motion Sickness Pills Market Size, 2018-2029
6.7.3 Israel Motion Sickness Pills Market Size, 2018-2029
6.7.4 Saudi Arabia Motion Sickness Pills Market Size, 2018-2029
6.7.5 UAE Motion Sickness Pills Market Size, 2018-2029
7 Motion Sickness Pills Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Motion Sickness Pills Major Product Offerings
7.1.4 GlaxoSmithKline Motion Sickness Pills Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Prestige Brands
7.2.1 Prestige Brands Company Summary
7.2.2 Prestige Brands Business Overview
7.2.3 Prestige Brands Motion Sickness Pills Major Product Offerings
7.2.4 Prestige Brands Motion Sickness Pills Revenue in Global Market (2018-2023)
7.2.5 Prestige Brands Key News & Latest Developments
7.3 WellSpring Pharmaceutical Corporation
7.3.1 WellSpring Pharmaceutical Corporation Company Summary
7.3.2 WellSpring Pharmaceutical Corporation Business Overview
7.3.3 WellSpring Pharmaceutical Corporation Motion Sickness Pills Major Product Offerings
7.3.4 WellSpring Pharmaceutical Corporation Motion Sickness Pills Revenue in Global Market (2018-2023)
7.3.5 WellSpring Pharmaceutical Corporation Key News & Latest Developments
7.4 Baxter International
7.4.1 Baxter International Company Summary
7.4.2 Baxter International Business Overview
7.4.3 Baxter International Motion Sickness Pills Major Product Offerings
7.4.4 Baxter International Motion Sickness Pills Revenue in Global Market (2018-2023)
7.4.5 Baxter International Key News & Latest Developments
7.5 Vartaris
7.5.1 Vartaris Company Summary
7.5.2 Vartaris Business Overview
7.5.3 Vartaris Motion Sickness Pills Major Product Offerings
7.5.4 Vartaris Motion Sickness Pills Revenue in Global Market (2018-2023)
7.5.5 Vartaris Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Motion Sickness Pills Major Product Offerings
7.6.4 Novartis Motion Sickness Pills Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Motion Sickness Pills Major Product Offerings
7.7.4 Pfizer Motion Sickness Pills Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Myungmoon Pharm
7.8.1 Myungmoon Pharm Company Summary
7.8.2 Myungmoon Pharm Business Overview
7.8.3 Myungmoon Pharm Motion Sickness Pills Major Product Offerings
7.8.4 Myungmoon Pharm Motion Sickness Pills Revenue in Global Market (2018-2023)
7.8.5 Myungmoon Pharm Key News & Latest Developments
7.9 Caleb Pharmaceuticals
7.9.1 Caleb Pharmaceuticals Company Summary
7.9.2 Caleb Pharmaceuticals Business Overview
7.9.3 Caleb Pharmaceuticals Motion Sickness Pills Major Product Offerings
7.9.4 Caleb Pharmaceuticals Motion Sickness Pills Revenue in Global Market (2018-2023)
7.9.5 Caleb Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report